Response to autografting and allografting
Patient/sex . | Prior to auto . | After auto . | After allo . |
---|---|---|---|
1. M | PR | CR | CR |
2. M | PR | CR | CR |
3. M | PR | PR | NE |
4. M | PR | PR | CR |
5. M | PR | PR | CR |
6. M | PR | CR | CR |
7. F | MR | MR | PR4-150 |
8. M | PR | PR | CR |
9. M | PR | PR | PR |
10. F | NC | NC | PR4-151 |
11. F | PR | PR | CR |
12. M | PR | PR | CR |
13. M | PR | PR | CR |
14. M | PR | PR | CR |
15. M | MR | MR | NE |
16. F | MR | PR | CR |
17. F | NC | NC | MR4-150 |
Overall CR | 0% | 18% | 73% |
Patient/sex . | Prior to auto . | After auto . | After allo . |
---|---|---|---|
1. M | PR | CR | CR |
2. M | PR | CR | CR |
3. M | PR | PR | NE |
4. M | PR | PR | CR |
5. M | PR | PR | CR |
6. M | PR | CR | CR |
7. F | MR | MR | PR4-150 |
8. M | PR | PR | CR |
9. M | PR | PR | PR |
10. F | NC | NC | PR4-151 |
11. F | PR | PR | CR |
12. M | PR | PR | CR |
13. M | PR | PR | CR |
14. M | PR | PR | CR |
15. M | MR | MR | NE |
16. F | MR | PR | CR |
17. F | NC | NC | MR4-150 |
Overall CR | 0% | 18% | 73% |